Evidence map›Paper›PMID 22253516›Full record

ReviewWorld journal of gastroenterology2012

Role of genetics in the diagnosis and prognosis of Crohn's disease.

Epameinondas V Tsianos, Konstantinos H Katsanos, Vasileios E Tsianos

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 7 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 7 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Adalimumab for induction of remission in Crohn's disease.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Natalizumab for induction of remission in Crohn's disease.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. ACG Clinical Guideline: Management of Crohn's Disease in Adults.The American journal of gastroenterology · 2018
    Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?Frontiers in cellular and infection microbiology · 2024
    Review
  15. Article
  16. Article
  17. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease.International journal of general medicine · 2021
    Review
  18. Article
  19. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases.Pediatric gastroenterology, hepatology & nutrition · 2019
    Review
  20. AInternational journal of medical sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Epameinondas V Tsianos1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Department of Medicine, Medical School, University of Ioannina, Leoforos Stavrou Niarxou, PO Box 1186, 45110 Ioannina, Greece. etsianos@uoi.gr
Konstantinos H Katsanos
Vasileios E Tsianos
University of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease. It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation. Several genes have been so far related to the diagnosis of Crohn's disease. Those genes are related to innate pattern recognition receptors, to epithelial barrier homeostasis and maintenance of epithelial barrier integrity, to autophagy and to lymphocyte differentiation. So far, the most strong and replicated associations with Crohn's disease have been done with NOD2, IL23R and ATG16L1 genes. Many genes have so far been implicated in prognosis of Crohn's disease and many attempts have been made to classify genetic profiles in Crohn's disease. CARD15 seems not only a susceptibility gene, but also a disease-modifier gene for Crohn's disease. Enriching our understanding on Crohn's disease genetics is important but when combining genetic data with functional data the outcome could be of major importance to clinicians.

Indexed as

PrognosisAutophagy-Related ProteinsCarrier ProteinsCrohn DiseaseGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansIntestinal MucosaNod2 Signaling Adaptor ProteinOrganic Cation Transport ProteinsReceptors, InterleukinATG16L1 protein, humanAutophagy-Related ProteinsCarrier ProteinsIL23R protein, humanNod2 Signaling Adaptor ProteinOrganic Cation Transport ProteinsReceptors, InterleukinCrohn’sDiagnosisGenetic consortiumGeneticsGenome wide scanPolymorphismPrognosis

Identifiers

PMID22253516
PMCPMC3257437
OpenAlexW1966182769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.